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Curcumin,a natural polyphenol obtained from turmeric,has been implicated to be neuroprotective in a variety of
neurodegenerative disorders although the mechanism remains poorly understood. The results of our recent
experiments indicated that curcumin could protect dopaminergic neurons from apoptosis in a 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease (PD). The death of dopaminergic neurons and
the loss of dopaminergic axon in the striatum were significantly suppressed by curcumin in MPTP mouse model.
Further studies showed that curcumin inhibited JNKs hyperphosphorylation induced by MPTP treatment. JNKs
phosphorylation can cause translocation of Bax to mitochondria and the release of cytochrome c which both
ultimately contribute to mitochondria-mediated apoptosis. These pro-apoptosis effect can be diminished by
curcumin. Our experiments demonstrated that curcumin can prevent nigrostriatal degeneration by inhibiting the
dysfunction of mitochondrial through suppressing hyperphosphorylation of JNKs induced by MPTP. Our results
suggested that JNKs/mitochondria pathway may be a novel target in the treatment of PD patients.Introduction
Parkinson’s disease (PD) is second only to Alzheimer’s
disease (AD) as the most common and debilitating age-
associated human neurodegenerative disorder. A host of
environmental, genetic, and immune cues have been
associated with the onset of this disease [1]. Clinical
symptoms of PD include tremor, bradykinesia, rigidity,
and postural instability [2,3]. Pathologically, it is charac-
terized by gliosis and progressive degeneration of the
dopaminergic neurons associated with the presence of
intracytoplasmic inclusions (Lewy bodies) in the sub-
stantia nigra pars compacta (SNc) [2,3]. The symptoms
of PD can be alleviated by drugs that enhance dopamine
function, among which L-dopa is considered the most
effective one. However, L-dopa fails to halt the* Correspondence: jqding18@yahoo.com; chen_sd@medmail.com.cn
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reproduction in any medium, provided the orprogression of PD. Aside from having undesirable side
effects, such as motor fluctuations and dyskinesias, the
therapeutic effect of L-dopa diminishes after about two
years of treatment [4]. Moreover, long term use of L-
dopa may actually damage neurons, accelerating neur-
onal apoptosis. Since programmed cell death plays a key
role in the neurodegenerative processes in PD [5], new
generation of neuroprotective agents against apoptosis
may improve the prognosis of PD.
Curcumin has been implicated to be neuroprotective
in a variety of neurodegenerative disorders such as AD
and cerebral ischemi [6,7]. Epidemiological evidence
from India has related the huge consumption of tur-
meric (curcumin is its essential component) to its lowest
prevalence rates of AD and PD in the world [8]. As a
matter of fact, curcumin is now in Phase II clinical trials
for AD [9]. Curcumin has been reported to be a good in-
hibitor of c-Jun N-terminal kinase (JNK) mediated gene
transcription [10]. JNK is a important member of
mitogen-activated protein kinases (MAPK) family, which
can be activated by a variety of stimuli including. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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agents [11-13]. JNK is composed of three different iso-
forms, JNK1, JNK2 and JNK3. In contrast to JNK1 and
JNK2, which are ubiquitously expressed, JNK3 is largely
restricted to the brain and is most consistently asso-
ciated with neuronal death [14] Our previous studies
and others suggested that JNK plays an important role
in mediating MPTP-induced neurotoxicity. CEP1347, a
specific JNK pathway inhibitor, attenuates the loss of
nigrostriatal dopaminergic neurons after the exposure to
MPTP [15] SP600125 (a selective inhibitor of JNK) pre-
vents dopaminergic neurons from death and decreases
the loss of catecholamines in the striatum [16] by par-
tially inhibiting JNK pathway. Therefore, it is reasonable
to assume that blockade of JNK pathway may prevent or
effectively slow down the progression of PD. Neverthe-
less, an understanding of the molecular mechanisms by
which JNK regulates apoptosis should provide insights
into the treatment of PD.
Previous studies demonstrated that JNK can promote
cell death by regulating the activation of substrates, such
as Bcl-2 family members [17]. The Bcl-2/Bax heterodi-
mer is the active component for death protection
[18,19]. Phosphorylation of Bcl-2 may possibly release
Bax from Bcl-2/Bax dimmers [20-22]. The preapototic
protein Bax forms pores in the outer mitochondrial
membrane to release cytochrome c [23], thus promoting
apoptosis,. On death induction, cytochrome c not only
translocates into the cytosol, but furthermore can be
abundantly detected in the extracellular medium. Thus,
release of cytochrome c is considered as an indication of
mitochondrial dysfunction [24]. It is therefore possible
that through regulating the activation of some Bcl-2
family members, activated JNK pathway increase mito-
chondrial membrane permeability and the subsequent
release of apoptogenic factors, which could ultimately
contribute to mitochondria mediated apoptosis.
Whether curcumin could inhibit the abnormal acti-
vation of JNK induced by MPTP, thus prevent the trig-
gering of a series downstream effects that lead to
apoptosis is unknown. In this study, the inhibitory ef-
fect of curcumin to the MPTP-induced activation of
JNK was evaluated. Using a MPTP-induced PD mice
model, we demonstrated that curcumin could suppress
the activation of the JNK in PD mice induced by
MPTP. Furthermore we demonstrated that curcumin
could decrease MPTP-induced injuries to dopaminergic




Studies were conducted in male C57BL/6 mice
(8 ~ 10 weeks old, weighing 19 ~ 22 g). Five animals werehoused per cage in a temperature-controlled (25°C) room
under a 12:12-h light:dark cycle with ad libitum access to
food and water for 1 week before the experiment. The
mice were injected intraperitoneally (i.p.) 5 times (for five
consecutive days) with 30 mg/kg/day MPTP-HCl (Sigma,
St. Louis, MO) or a corresponding volume of saline
alone. One day after the last MPTP injection, the curcu-
min treated mice groups were treated with an intraperi-
toneal injection of curcumin (sigma) at 50 mg/kg/day for
five consecutive days. Equal dose of DMSO instead of
curcumin were given to the control group. At the indi-
cated time points, the animals were killed, and their
brains were processed for further analysis.Immunohistochemistry
Mice were perfusion-fixed on Day 10 with 4% parafor-
maldehyde in 0.1 M sodium phosphate buffer (pH 7.4).
Brains were removed quickly and further fixed with the
same fixation solution at 4°C overnight. Post-fixed brains
were embedded by paraffin, followed by preparation of
coronal sections using a microtome. The paraffin-
embedded brain sections were deparaffinized with xylene
and rehydrated by ethanol at graded concentrations of
100-70% (v/v), followed by washing with water.
Immunoreactivity was determined by the avidin–bio-
tin–peroxidase method. Briefly, sections were deparaffi-
nized with xylene and rehydrated by ethanol at graded
concentrations and distilled water. High-temperature
antigen retrieval was performed in 1 mM citrate buffer
for 15 min. To block endogenous peroxidase activity,
sections were incubated for 30 min in 1% H2O2. After
being blocked with 5%(v/v) normal goat serum in PBS
for 1 h at 37°C, sections were incubated with a mouse
polyclonal antibody against tyrosine hydroxylase (TH,
1:8000) at 4°C for 24 hours. These sections were then
incubated with biotinylated goat-anti-mouse secondary
antibody overnight and subsequently with avidin–conju-
gated horseradish peroxidase for 1 h at 37°C. Finally,
sections were incubated with peroxidase substrate dia-
minobenzidine (DAB) until desired stain intensity devel-
oped [25].Electron Microscopy
Mitochondria isolated from ischemic and reperfused
myocardial tissue in several kinds of buffer by density
centrifugation was resuspended and fixed with 2% glu-
taraldehyde in 0.1 M PBS buffer. Mitochondria were
post-fixed utilizing 1% OsO4. En bloc staining with ur-
anyl acctate was followed by dehydration and embed-
ding. Embedded samples were sectioned and affixed to
grids according to standard protocols. Mitochondrial
ultrastructure was then evaluated by transmission
microscopy.
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Tissue homogenates (400 μg of protein) were diluted
four-fold with 50 mM HEPES buffer (pH 7.4), containing
10% glycerol, 150 mM NaCl, 1% Triton X-100, 0.5% NP-
40, and 1 mM each of EDTA, EGTA, PMSF and Na3VO4.
Samples were preincubated for 1 h with 20 μl protein A
sepharose CL-4B (Amersham, Uppsala, Sweden) at 4°C,
and then centrifuged to remove proteins adhered non-
specifically to protein A. The supernatants were incu-
bated with 1-2 μg primary antibodies for 4 h or overnight
at 4°C. Protein A was added to the tube for another 2 h
incubation. Samples were centrifuged at 10,000 × g for
2 min at 4°C and the pellets were washed with HEPES
buffer for three times. Bound proteins were eluted by
boiling at 100°C for 5 min in SDS-PAGE loading buffer
and then isolated by centrifugation. The supernatants
were used for immunoblotting analysis. Proteins were
separated on polyacrylamide gels and then electrotrans-
ferred onto a nitrocellulose membrane (Amersham,
Buckinghamshire, UK). After being blocked for 3 h in
Tris-buffered saline with 0.1% Tween-20 (TBST) and 3%
bovine serum albumin (BSA), membranes were incu-
bated overnight at 4°C with primary antibodies in TBST
containing 3% BSA. After washing for 30 min in TBS
with gentle agitation, the membrane was incubated with
horseradish peroxidase-conjugated anti-mouse/rabbit
IgG secondary antibody at room temperature for 2 h
([26–28]). Signals were developed using ECL Western
Blotting Detection kit (Amersham-Pharmacia Biotech,
Little Chalfont, UK). Band intensities were quantified by
densitometric analyses using an AxioCam digital camera
(ZEISS, CTED PROOF Germany) and a KS400 photo
analysis system (Version 3.0).
Statistical evaluation
Values were expressed as mean S.D. and obtained from
at least six independent experiemnts. Statistical analysis
of the results was carried out by Student’s t-test or
one-way analysis of the variance (ANOVA) followed by
the Duncan’s new multiple range method or Newman-
Keuls test. P-values less than 0.05 were considered
significant.
Results
Effects of curcumin on MPTP-induced loss of
dopaminergic neurons
To investigate whether treatment of curcumin would
have neuroprotection againstMPTP-induced dopaminergic
neuronal death, C57BL/6 mice were subjected MPTP
lesion. Mice were treated with curcumin or DMSO by in-
jection for 5 consecutive days after last MPTP injection.
We first examined the effect of curcumin on tyrosine
hydroxylase (TH)-positive neurons in SNc of MPTP ani-
mal model. As shown in Figure 1A (I), MPTP inducedmarked nigral cell death (Figure 1 A(II)). However, ad-
ministration of curcumin clearly rescued the neurode-
generation caused by MPTP (Figure 1A (IV)). At the
same time, as the control, DMSO did not show any
protection (Figure 1A (III)). The results indicated that
curcumin was capable of protecting neurons against
MPTP-induced injury. TH immunostaining in the stri-
atum was assessed as an indication of dopaminergic
axon. The results revealed curcumin treatment mini-
mized the decreased densities of dopaminergic axon in
the caudate-putamen (CP) region of the striatum
(Figure 1A (iv)), while the DMSO did not have such
effect (Figure 1A (iii)).
Electron micrographs analysis of morphology of
mitochondria isolated
With mitochondrial dysfunction being thought to be
related to cell death [29]. We tested whether morph-
ology of mitochondria isolated from correlation is in ac-
cordance with curcumin treatment significantly reducing
infarct size. Electron microscopy reveals basically formed
membranes and clearly descernable cristae in the mito-
chondria isolated from saline and curcumin treatment
mouse. Whereas the mitochondria isolated from control
groups were severely swollen, with partially disrupted
outer membrane and fragmentation of the cristae. Fur-
thermore, mitochondria in curcumin group appear to
morphologically be better than that from other groups
(Figure 2).
Effects of curcumin on MPTP-treated activation and
expression of JNKs
JNK signaling is an important contributor to MPTP-
induced apoptosis, but JNK and its isoforms (JNK1,
JNK2, and JNK3) have distinct roles. As aforementioned,
targeted disruption of the Jnk3 gene not only reduced
the downstream effector c-Jun phosphorylation, but also
remarkably protected mice from brain injury after
MPTP lesion. These studies indicate the functional di-
versity of JNK isoforms and suggest that JNK3 is a crit-
ical component of MPTP-induced JNK signaling and
neuronal apoptosis.
To elucidate the effects of curcumin on the activation
of JNKs, JNK1/2/3 phosphorylation were investigated in
MPTP lesioned animals. As indicated in Figures 3, the
results of western blots showed that the phosphorylation
and total level of JNK1/2 and JNK3 were significantly
increased after MPTP injection. However, as shown in
Figure 3, the treatment of curcumin remarkably inhib-
ited the phorsphorylation of JNK3 rather than JNK1 and
2. The same dose of DMSO did not have the same effect.
The protein levels of JNKs were not affected by either
curcumin or DMSO treatment. Our study demonstrates
that treatment of curcumin attenuated the activation of






































Figure 1 Effects of curcumin on cell death and survival in SNc. Curcumin attenuated MPTP-induced DA terminal loss in striatum and
dopaminergic neuronal death in the SNc. TH-stained sections of SNc in saline group (I), mice subjected MPTP-induced lesion (II), administration of
the curcumin (III) and DMSO (IV) following MPTP injection. When compared to Curcumin treated mice (iv), DMSO-treated mice following MPTP
lesion showed marked reduction in TH positive fibres in striatum (iii). (i, ii) TH staining in striatum of saline and MPTP-treated mice. Scale bars:
(I,II,III,IV) =400 μm; (i,ii,iii,iv) =100 μm. (B) Quantitative analysis of the protective effects of curcumin against MPTP-induced mice model of
nigrostriatal damage. aP< 0.05 vs. saline control bP <0.05 vs. MPTP injection groups.
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over, the fact that the level of JNK3 activation was inhib-
ited more than that of JNK1/2 activation in vivo
indicated that the activation of JNK3 is more important
in the mechanism of dopaminergic neuronal death
induced by MPTP.
Curcumin inhibits the phosphorylation of Bcl-2 and the
release of Bax from Bcl-2/Bax dimmers
JNK can promote cell death by regulating the activation
of some non-nuclear substrates, such as Bcl-2 family
members. Previous studies have also indicated that phos-
phorylation inactivates Bcl-2, thus promoting apoptosis,
possibly by freeing Bax from Bcl-2/Bax dimmers. The
Bcl-2/Bax heterodimer is the active component for death
protection. Our previous study indicated that K252a (the
inhibitor of JNK upsteam) rescued 6-OHDA-induced
dopaminergic neuronal death in SNc via suppressing the
phosphorylation of Bcl-2 [25]. Since curcumin could in-
hibit the activation of JNK, we supposed that treatment
of curcumin should have the ability to inhibit the phos-
phorylation of Bcl-2 proteins, increase the interaction of
Bcl-2 with Bax. Similar to the result, curcumin inhibited
the phosphorylation of Bcl-2 in SNc (Figure 4A and B).In this study, we found that phosphorylated Bcl-2 was
not shown to interact with Bax during MPTP lesion
(data not shown). Furthermore, our results demon-
strated that MPTP decreased interaction of Bcl-2 with
Bax and curcumin inhibited the decreased interaction of
Bcl-2 with Bax (Figure 4B).
Curcumin attenuates Bax translocation and the release of
cytochrome c
To elucidate the involvement of mitochondria-mediated
apoptotic pathway during MPTP lesion and the action
of JNK activity on Bax translocation and the release of
cytochrome c, level of Bax and cytochrome c in mito-
chondria and cytosol was examined by Western blotting.
We first determined whether Bax translocates from
cytosol to mitochondria after lesion. Using Western
blotting analysis on different subcellular fraction, we
found that the level of Bax was significantly increased in
the mitochondria, but the level of Bax was not markedly
decreased in cytosol (Figure 5A). We assume that the
overwhelming majority of Bax were located in cytosol,
thus partial translocation of Bax did not significantly
affect the total protein level of Bax in cytosol. Moreover,
we examined whether the inhibition of JNKs by
Figure 2 Electron micrographs analysis of morphology of mitochondria isolated. Structural analysis of mitochondria isolated from saline
group (A), mice subjected MPTP-induced lesion (B), administration of the curcumin (D) and DMSO (C) following MPTP injection. Following
isolation,mitochondria were processed for electron microscopic analysis as described in Materials and Methods. Electron micrographs are at a
magnification of 10,000X (n = 2).
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The inhibitory effect of curcumin on Bax translocation
in the mitochondrial fraction reached a statistical differ-
ence compared with DMSO (Figure 5). A significant
amount of mitochondrial cytochrome c was detected in
the saline controls and decreased after MPTP lesion,
corresponding to a marked increase in the cytosolic frac-
tion (Figure 5). The inhibitory effect of curcumin on the
release of cytochrome c in the cytosol fraction reached a
statistical difference compared DMSO (Figure 5). To
elucidate whether other mitochondrial proteins were
released from mitochondria, we determined the cyto-
chrome c oxidase level in the cytosolic and mitochon-
drial fraction using cytochrome c oxidase subunit IV
antibody. The cyt c oxidase subunit IV was detected
only in the mitochondrial fraction but not in the cyto-
solic fraction in saline, MPTP lesion and application of
curcumin groups (Figure 5). These results suggested that
cytochrome c oxidase was not co-released with cyto-
chrome c from mitochondria.
Discussion
The most direct evidence for disrupted mitochondrial
metabolism has come from studies of autopsy tissue andother tissue samples and in vitro cell cultures derived
from patients with PD [30]. Mitochondrial dysfunction,
due to either environmental or genetic factors, can trig-
ger the apoptotic death of dopaminergic cells in PD. As
a matter of fact, results from western blot and electron
microscope indicated that cytochrome c releasing and
mitochondrial intact were destroyed in MPTP mice. The
Bcl-2/Bax heterodimer is the active component for death
protection. Previous studies have also indicated that
phosphorylation inactivates Bcl-2, thus promoting apop-
tosis, possibly by freeing Bax from Bcl-2/Bax dimmers
[20-22] ,The proapoptotic protein Bax released from
Bcl-2/Bax dimmers and act as the channels for either
ions or proteins by forming pores in the outer mito-
chondrial membrane that release cytochrome c [31].
The phosphorylation of Bcl-2 is regulated by JNK
[32,33].
A large and growing of evidence suggests that the JNK
pathway can function in a pro-apoptotic manner. In vivo,
the small molecule CEP-1347 inhibits MPTP-mediated
JNK signaling at a dose that attenuates MPTP-mediated
nigrostriatal dopaminergic loss [15]. In addition, SP600125
also increases striatal catecholamine concentrations, result-
































































Figure 3 Effects of curcumin on the phosphorylation of JNKs.
Effects of curcumin on the phosphorylation of JNKs in SNc. Bands
corresponding to JNK3 and p-JNK3 were scanned and the intensities
were represented as folds vs. saline animals. Phosphorylation of JNK3
was examined by immunoprecipitation (IP) with anti-p-JNKs
antibody followed by immunoblotting (IB) with antibody against
JNK3. P-JNK1/2 was examined by IB with antibody against p-JNK1/2.
The protein levels of JNK1/2 and J NK3 were examined by
immunoblotting with anti-JNK1/2 and anti-JNK3 antibodies. Data are
expressed as the mean± SD and as folds vs. respective saline
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Figure 4 Effects of curcumin on the altered phosphorylation of
Bcl-2 and interactions of Bcl-2 with Bax. (A) Effects of curcumin on
the increased phosphorylation of Bcl-2 induced by MPTP in SNc.
Western blot probed with antibodies to phosphorylated Bcl-2 (p-Bcl-2,
Ser87) and Bcl-2. Bands corresponding to p-Bcl-2 and Bcl-2 were
scanned and the intensities were represented as folds vs. saline groups.
Data are expressed as mean± SD (n = 6). aP< 0.05 vs. respective saline,
bP< 0.05 vs. MPTP groups. (B) Co-immunoprecipitation analysis of
interactions between Bcl-2 and Bax. Bands corresponding to Bax and
Bcl-2 were scanned and the intensities were represented as folds vs.
saline groups. Data are expressed as mean± SD. aP< 0.05 vs. respective
saline, bP< 0.05 vs. MPTP groups. (n = 6 mice).
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Figure 5 Curcumin attenuated the mitochondrial apoptosis-signaling pathway in SNc. (A) Effects of curcumin on the level of Bax induced
by MPTP in cytosol and mitochondria in SNc. (B) Effects of curcumin on the level of cyt c induced by MPTP in cytosol and mitochondria in SNc.
COX4 was strongly expressed in the mitochondrial fraction and did not decrease after MPTP lesion, while no immunoreactivity was seen in the
cytosolic fraction of SNc region in both the saline and MPTP groups. Bands corresponding to Bax and cyt c were scanned and the intensities
were represented as folds vs. saline groups. Data are expressed as the mean± SD and as folds vs. respective saline. aP< 0.05 vs. saline; bP <0.05 vs.
MPTP groups (n = 6 mice).
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esablished to exert neuroprotection in animal models of
degenerative diseases such as cerebral ischemia, Alzhei-
mer’s disease [9,34,35]. Our previous study and others sug-
gested that JNK3 plays a more important role than JNK1/2
in neuron death and may serve as a potential target for
neuroprotective therapies. Ablation of JNKs can not only
protect dopaminergic neurons against MPTP-induced neu-
rodegeneration but also improve the motor function in
mouse model of PD [36]. As a matter of fact, results from
western blot and immunoprecipitation show high fidelity
to our hypothesis that curcumin could inhibiteJNKs
activation.
Our study also shows that curcumin could attenuate
the phosphorylation of Bcl-2 proteins, increase the inter-
action of Bcl-2 with Bax, and prevent Bax from translo-
cating to sytosol induced by MPTP. Furthermore,
curcumin keeps the mitochondria integrity and pre-
serves cytochrome c loss from mitochondria which
normally is considered critical role in apoptosis MPTP-
intoxicated mice. Since curcumin treatment can inhibit
the activation of JNKs mitochondria pathway induced by
MPTP lesion, we inferred that application of curcumin
would also restore dopaminergic terminals as well as
SNc cell bodies from degeneration. Our present studyindicated that curcumin actually had the ability to pre-
vent dopaminergic neurons from degeneration following
MPTP insult. At the same time, results from TUNEL
provided strong evidence that curcumin could protect
the dopaminergic neurons from apoptosis. Moreover,
curcumin is the major monomer from turmeric extract.
Turmeric has been utilized in traditional Indian cuisine
and medicine without any known major toxic effect [37].
Thus, the protective effect of curcumin shown here is
likely clinically relevant, as significant neuroprotection
was achieved when curcumin was administered after the
onset of PD. At the same time, we can conclude that se-
lective inhibition of JNKs mitochondria pathway activa-
tion may be of therapeutic benefit for PD patients.
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